Signe Mølhøj

Summary

Publications

  1. ncbi Effect of the cannabinoid receptor-1 antagonist rimonabant on lipolysis in rats
    Signe Mølhøj
    Diabetes and Obesity Pharmacology, Novo Nordisk A S, Denmark
    Eur J Pharmacol 646:38-45. 2010

Collaborators

Detail Information

Publications1

  1. ncbi Effect of the cannabinoid receptor-1 antagonist rimonabant on lipolysis in rats
    Signe Mølhøj
    Diabetes and Obesity Pharmacology, Novo Nordisk A S, Denmark
    Eur J Pharmacol 646:38-45. 2010
    ..In conclusion, the present study suggests an acute lipolytic effect of rimonabant mediated through activation of the sympathoadrenal system...